Capital Management Associates (New York)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $527K | Hold |
1,300
| – | – | 0.86% | 39 |
|
|
2025
Q1 | $647K | Hold |
1,300
| – | – | 1.26% | 33 |
|
|
2024
Q4 | $676K | Hold |
1,300
| – | – | 0.8% | 47 |
|
|
2024
Q3 | $804K | Sell |
1,300
-200
| -13% | -$124K | 0.9% | 47 |
|
|
2024
Q2 | $830K | Hold |
1,500
| – | – | 0.98% | 43 |
|
|
2024
Q1 | $872K | Hold |
1,500
| – | – | 1.04% | 43 |
|
|
2023
Q4 | $796K | Hold |
1,500
| – | – | 1.01% | 46 |
|
|
2023
Q3 | $759K | Hold |
1,500
| – | – | 1.12% | 33 |
|
|
2023
Q2 | $783K | Hold |
1,500
| – | – | 1.15% | 36 |
|
|
2023
Q1 | $865K | Hold |
1,500
| – | – | 1.31% | 32 |
|
|
2022
Q4 | $826K | Sell |
1,500
-1,200
| -44% | -$661K | 1.23% | 39 |
|
|
2022
Q3 | $1.37M | Hold |
2,700
| – | – | 1.99% | 14 |
|
|
2022
Q2 | $1.47M | Hold |
2,700
| – | – | 2.16% | 14 |
|
|
2022
Q1 | $1.6M | Sell |
2,700
-900
| -25% | -$532K | 1.71% | 17 |
|
|
2021
Q4 | $2.4M | Hold |
3,600
| – | – | 2.35% | 8 |
|
|
2021
Q3 | $2.06M | Hold |
3,600
| – | – | 2.03% | 12 |
|
|
2021
Q2 | $1.82M | Hold |
3,600
| – | – | 1.74% | 12 |
|
|
2021
Q1 | $1.64M | Hold |
3,600
| – | – | 1.69% | 14 |
|
|
2020
Q4 | $1.68M | Hold |
3,600
| – | – | 1.83% | 11 |
|
|
2020
Q3 | $1.59M | Hold |
3,600
| – | – | 2.1% | 11 |
|
|
2020
Q2 | $1.3M | Hold |
3,600
| – | – | 1.84% | 15 |
|
|
2020
Q1 | $1.02M | Buy |
3,600
+600
| +20% | +$170K | 1.84% | 16 |
|
|
2019
Q4 | $975K | Hold |
3,000
| – | – | 1.35% | 25 |
|
|
2019
Q3 | $874K | Hold |
3,000
| – | – | 1.35% | 22 |
|
|
2019
Q2 | $881K | Hold |
3,000
| – | – | 1.43% | 17 |
|
|
2019
Q1 | $821K | Hold |
3,000
| – | – | 1.28% | 24 |
|
|
2018
Q4 | $671K | Hold |
3,000
| – | – | 1.27% | 25 |
|
|
2018
Q3 | $732K | Hold |
3,000
| – | – | 0.91% | 36 |
|
|
2018
Q2 | $621K | Buy |
+3,000
| New | +$621K | 0.78% | 55 |
|